Free multilingual Parkinson’s document helps patients travelling abroad

Resources & Tools

Author: Parkinson's Life editorsPublished: 7 April 2016

Prep: Cook: Serves:

Are you going abroad? Whether you’re travelling for work or pleasure, letting people know about your condition in their native language could save you in an emergency

The ‘PD Doc’ is a free downloadable resource that lets people know about your Parkinson’s disease when you are in a foreign country – it is available in 25 languages, from Chinese to German. In an emergency, it’s important that people are made aware of your condition, so they can get you the right help.

PD Doc languages

This simple document clearly identifies the person with Parkinson’s and their condition, as well as listing emergency contact details.

You can personalise your own PD Doc print out to include several languages. For example, if you are travelling in Switzerland you can print in German, Italian and French.

PD Doc in Croatian

The PD Doc was developed by the European Parkinson’s Disease Association in association with healthcare professionals and industry partners.

The PD Passport is a more advanced version of PD Doc, allowing users to store additional information on medications and therapies.

Download the PD Doc for free here

Last Month

Next Month

Go Back

Share this story

Comments

Special reports

Neurologists should be ‘guides not gods’ – Part 1

Why physicians need to come down from their 'ivory towers'

“I hope it empowers people with Parkinson’s to be more open and honest”

Canadian artist Anita Kunz talks Parkinson’s and art

Special reports

STEP – The lived experience of Parkinson’s disease

STEP™ hopes to give a voice to people living with Parkinson’s

Musical therapy study to receive $20 million in funding

The National Institutes of Health (NIH) is donating US $20 million to a medical trial researching the effects of musical therapy on brain conditions, including Parkinson’s. The trial will be carried out by the Sound Health initiative, a joint partnership between the NIH and The John F Kennedy Center for the Performing Arts. The initiative was created to expand current knowledge of how listening, performing and creating music could be harnessed for health and wellness. Francis S. Collins, director of the NIH, said: “We know that the beat of a metronome can steady the gait of someone with Parkinson’s disease, for example, but we don’t fully understand how that happens. “If we can pinpoint in the brain how music therapy works through the use of imaging and biomarkers, the hope is that we can improve its effectiveness and apply it more broadly to improve the lives of millions of people.”

Researchers develop automated system to diagnose Parkinson’s

In an international study, researchers from the US, Germany and Austria have used a non-invasive MRI method to develop an automated system that can diagnose Parkinson’s. As part of the study – published in medical journal ‘The Lancet Digital Health’ – researchers worked with 1,002 patients and used an imaging method that measures how water molecules diffuse in the brain. This helped them to identify where neurodegeneration is occurring. Researchers hope this will help improve the accuracy of early Parkinson’s diagnoses – which they estimate to be around 58%. Dr David Vaillancourt, who led the study, said: “Our method may help to reduce the number of misdiagnosed cases in the future. Since these diseases require unique treatment plans and different medications, and clinical trials testing new medications require the correct diagnosis, getting it right is important for patient care.”

MJFF announces $10 million competition for Parkinson’s

The Michael J Fox Foundation has launched the ‘Ken Griffin Alpha-synuclein Imaging Competition’ – a US $10 million programme aiming to develop a game-changing tool for Parkinson’s research. As part of the competition, participating teams will compete in a scientific race to build a device that is able to identify alpha-synuclein – a protein closely associated with Parkinson’s. Although almost everyone diagnosed with Parkinson’s has clumps of alpha-synuclein in the brain, these are currently only visible when analysing tissue during autopsies. The competition is named after Ken Griffin, CEO of US investment firm Citadel who has given US $7.5 million funding to the programme. Griffin – whose father has Parkinson’s – said: “If we have the imaging capability to observe the pathology that arises from protein-misfolding in real time, and understand how drugs are impacting people in real time, that would be a major advance.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Free multilingual Parkinson’s document helps patients travelling abroad

Resources & Tools

Author: Parkinson's Life editorsPublished: 7 April 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Special reports

Neurologists should be ‘guides not gods’ – Part 1

Global update

“I hope it empowers people with Parkinson’s to be more open and honest”

sponsored article

Special reports

STEP – The lived experience of Parkinson’s disease

Musical therapy study to receive $20 million in funding

Researchers develop automated system to diagnose Parkinson’s

MJFF announces $10 million competition for Parkinson’s

{title}

Subscribe

Free multilingual Parkinson’s document helps patients travelling abroad

Resources & Tools

Author: Parkinson's Life editorsPublished: 7 April 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Special reports

Neurologists should be ‘guides not gods’ – Part 1

Global update

“I hope it empowers people with Parkinson’s to be more open and honest”

sponsored article

Special reports

STEP – The lived experience of Parkinson’s disease

Musical therapy study to receive $20 million in funding

Researchers develop automated system to diagnose Parkinson’s

MJFF announces $10 million competition for Parkinson’s

{title}

Subscribe

Sign in